Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection

The outbreak of SARS-CoV-2 infection has enormously impacted our lives. Clinical evidence has implicated the emergence of cytokine release syndrome as the prominent cause of mortality in COVID-19 patients. In this study, we observed massive elevation of plasma Galectin-9 (Gal-9) in COVID-19 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozorgmehr, Najmeh, Mashhouri, Siavash, Perez Rosero, Eliana, Xu, Lai, Shahbaz, Shima, Sligl, Wendy, Osman, Mohammed, Kutsogiannis, Demetrios J., MacIntyre, Erika, O’Neil, Conar R., Elahi, Shokrollah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262904/
https://www.ncbi.nlm.nih.gov/pubmed/33947753
http://dx.doi.org/10.1128/mBio.00384-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262904/
https://www.ncbi.nlm.nih.gov/pubmed/33947753
http://dx.doi.org/10.1128/mBio.00384-21

Ejemplares similares